An Evaluation on the Role of Non-Coding RNA in HIV Transcription and Latency: A Review

References

• Tyagi M, Bukrinsky M. Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication. Mol Med. 2012;18(7):1096–1108. doi:10.2119/molmed.2012.00194
   PubMed Web of Science ®Google Scholar
• Eisele E, Siliciano RF. Redefining the viral reservoirs that prevent HIV-1 eradication. Immunity. 2012;37(3):377–388. doi:10.1016/j.immuni.2012.08.010
   PubMed Web of Science ®Google Scholar
• Chun T-W, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 1997;387(6629):183–188. doi:10.1038/387183a0
   PubMed Web of Science ®Google Scholar
• Pasternak AO, Berkhout B. What do we measure when we measure cell-associated HIV RNA. Retrovirology. 2018;15(1):13. doi:10.1186/s12977-018-0397-2
   PubMedGoogle Scholar
• Chitrakar A, Sanz M, Maggirwar SB, Soriano-Sarabia N. HIV latency in myeloid cells: challenges for a cure. Pathogens. 2022;11(6):611. doi:10.3390/pathogens11060611
   PubMed Web of Science ®Google Scholar
• King VM, Borchert GM. MicroRNA expression: protein participants in microRNA regulation. In: Huang J, Borchert GM, Dou D, editors. Bioinformatics in MicroRNA Research. New York: Springer New York; 2017:27–37.
   Google Scholar
• Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466(7308):835–840. doi:10.1038/nature09267
   PubMed Web of Science ®Google Scholar
• Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011;12(2):99–110. doi:10.1038/nrg2936
   PubMed Web of Science ®Google Scholar
• Huang V, Place RF, Portnoy V, et al. Upregulation of cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res. 2012;40(4):1695–1707. doi:10.1093/nar/gkr934
   PubMed Web of Science ®Google Scholar
• Place RF, Li LC, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A. 2008;105(5):1608–1613. doi:10.1073/pnas.0707594105
   PubMed Web of Science ®Google Scholar
• Younger ST, Corey DR. Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters. Nucleic Acids Res. 2011;39(13):5682–5691. doi:10.1093/nar/gkr155
   PubMed Web of Science ®Google Scholar
• Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904–914. doi:10.1016/j.molcel.2011.08.018
   PubMed Web of Science ®Google Scholar
• Hung T, Chang HY. Long noncoding RNA in genome regulation: prospects and mechanisms. RNA Biol. 2010;7(5):582–585. doi:10.4161/rna.7.5.13216
   PubMed Web of Science ®Google Scholar
• Hashemi P, Sadowski I. Diversity of small molecule HIV-1 latency reversing agents identified in low- and high-throughput small molecule screens. Med Res Rev. 2020;40(3):881–908. doi:10.1002/med.21638
   PubMed Web of Science ®Google Scholar
• Rasmussen TA, Lewin SR. Shocking HIV out of hiding: where are we with clinical trials of latency reversing agents? Curr Opin HIV AIDS. 2016;11(4):394–401. doi:10.1097/COH.0000000000000279
   PubMed Web of Science ®Google Scholar
• Archin NM, Liberty AL, Kashuba AD, et al. Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature. 2012;487(7408):482–485. doi:10.1038/nature11286
   PubMed Web of Science ®Google Scholar
• Elliott JH, Wightman F, Solomon A, et al. Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy. PLoS Pathog. 2014;10(11):e1004473. doi:10.1371/journal.ppat.1004473
   PubMed Web of Science ®Google Scholar
• Rasmussen TA, Tolstrup M, Brinkmann CR, et al. Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a Phase 1/2, single group, clinical trial. Lancet HIV. 2014;1(1):e13–e21. doi:10.1016/S2352-3018(14)70014-1
   PubMed Web of Science ®Google Scholar
• Vansant G, Bruggemans A, Janssens J, Debyser Z. Block-and-lock strategies to cure HIV infection. Viruses. 2020;12(1):84. doi:10.3390/v12010084
   PubMed Web of Science ®Google Scholar
• Mousseau G, Kessing CF, Fromentin R, Trautmann L, Chomont N, Valente ST. The Tat inhibitor didehydro-cortistatin A prevents HIV-1 reactivation from latency. mBio. 2015;6(4):e00465–e00465. doi:10.1128/mBio.00465-15
   PubMed Web of Science ®Google Scholar
• Lu Y, Bohn-Wippert K, Pazerunas PJ, Moy JM, Singh H, Dar RD. Screening for gene expression fluctuations reveals latency-promoting agents of HIV. Proc Nat Acad Sci U S A. 2021;118(11):e2012191118. doi:10.1073/pnas.2012191118
   PubMed Web of Science ®Google Scholar
• Kyei GB, Meng S, Ramani R, et al. Splicing factor 3B subunit 1 interacts with HIV Tat and plays a role in viral transcription and reactivation from latency. mBio. 2018;9(6). doi:10.1128/mBio.01423-18
   PubMed Web of Science ®Google Scholar
• Mukim A, Smith DM, Deshmukh S, Qazi AA, Beliakova-Bethell N. A camptothetin analog, topotecan, promotes HIV latency via interference with HIV transcription and RNA splicing. J Virol. 2023;31:e0163022. doi:10.1128/jvi.01630-22
   Google Scholar
• Maina EK, Adan AA, Mureithi H, Muriuki J, Lwembe RM. A review of current strategies towards the elimination of latent HIV-1 and subsequent HIV-1 cure. Curr HIV Res. 2020;19(1):14–26.
   Web of Science ®Google Scholar
• Qu X, Wang P, Ding D, et al. Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells. Nucleic Acids Res. 2013;41(16):7771–7782. doi:10.1093/nar/gkt571
   PubMed Web of Science ®Google Scholar
• Ebina H, Kanemura Y, Misawa N, et al. A high excision potential of TALENs for integrated DNA of HIV-based lentiviral vector. PLoS One. 2015;10(3):e0120047. doi:10.1371/journal.pone.0120047
   PubMed Web of Science ®Google Scholar
• Karpinski J, Chemnitz J, Hauber I, et al. Universal Tre (uTre) recombinase specifically targets the majority of HIV-1 isolates. J Int AIDS Soc. 2014;17(4 Suppl 3):19706. doi:10.7448/IAS.17.4.19706
   PubMedGoogle Scholar
• Kaminski R, Chen Y, Fischer T, et al. Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR/Cas9 gene editing. Sci Rep. 2016;6(1):22555. doi:10.1038/srep22555
   PubMedGoogle Scholar
• Panfil AR, London JA, Green PL, Yoder KE. CRISPR/Cas9 genome editing to disable the latent HIV-1 provirus. Front Microbiol. 2018;9:3107. doi:10.3389/fmicb.2018.03107
   PubMed Web of Science ®Google Scholar
• Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22(9):1775–1789. doi:10.1101/gr.132159.111
   PubMed Web of Science ®Google Scholar
• Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25(18):1915–1927. doi:10.1101/gad.17446611
   PubMed Web of Science ®Google Scholar
• Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genom. 2007;8(1):166. doi:10.1186/1471-2164-8-166
   PubMedGoogle Scholar
• Kristen AV, Ajroud-Driss S, Conceição I, Gorevic P, Kyriakides T, Obici L. Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis. Neurodegener Dis Manag. 2019;9(1):5–23. doi:10.2217/nmt-2018-0033
   PubMed Web of Science ®Google Scholar
• Ruelas DS, Chan JK, Oh E, et al. MicroRNA-155 reinforces HIV latency. J Biol Chem. 2015;290(22):13736–13748. doi:10.1074/jbc.M115.641837
   PubMed Web of Science ®Google Scholar
• Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature. 1987;326(6114):711–713. doi:10.1038/326711a0
   PubMed Web of Science ®Google Scholar
• Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci U S A. 1989;86:2336–2340. doi:10.1073/pnas.86.7.2336
   PubMed Web of Science ®Google Scholar
• Modai S, Farberov L, Herzig E, Isakov O, Hizi A, Shomron N. HIV-1 infection increases microRNAs that inhibit Dicer1, HRB and HIV-EP2, thereby reducing viral replication. PLoS One. 2019;14(1):e0211111. doi:10.1371/journal.pone.0211111
   PubMed Web of Science ®Google Scholar
• Nomura N, Zhao MJ, Nagase T, et al. HIV-EP2, a new member of the gene family encoding the human immunodeficiency virus type 1 enhancer-binding protein. Comparison with HIV-EP1/PRDII-BF1/MBP-1. J Biol Chem. 1991;266(13):8590–8594. doi:10.1016/S0021-9258(18)93015-2
   PubMed Web of Science ®Google Scholar
• Chiang K, Sung T-L, Rice AP. Regulation of cyclin T1 and HIV-1 replication by microRNAs in resting CD4(+) T lymphocytes. J Virol. 2012;86(6):3244–3252. doi:10.1128/JVI.05065-11
   PubMed Web of Science ®Google Scholar
• Sung TL, Rice AP. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog. 2009;5(1):e1000263. doi:10.1371/journal.ppat.1000263
   PubMed Web of Science ®Google Scholar
• Triboulet R, Mari B, Lin Y-L, et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science. 2007;315(5818):1579–1582. doi:10.1126/science.1136319
   PubMed Web of Science ®Google Scholar
• Seddiki N, Phetsouphanh C, Swaminathan S, et al. The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection. Eur J Immunol. 2013;43(2):510–520. doi:10.1002/eji.201242695
   PubMed Web of Science ®Google Scholar
• Kaczmarek Michaels K, Natarajan M, Euler Z, Alter G, Viglianti G, Henderson AJ. Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells. J Immunol. 2015;194(7):3267–3274. doi:10.4049/jimmunol.1402581
   PubMed Web of Science ®Google Scholar
• Yu J, Angelin-Duclos C, Greenwood J, Liao J, Calame K. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol. 2000;20(7):2592–2603. doi:10.1128/MCB.20.7.2592-2603.2000
   PubMed Web of Science ®Google Scholar
• Thiele S, Wittmann J, Jäck H-M, Pahl A. miR-9 enhances IL-2 production in activated human CD4+ T cells by repressing Blimp-1. Eur J Immunol. 2012;42(8):2100–2108. doi:10.1002/eji.201142203
   PubMed Web of Science ®Google Scholar
• Chinnapaiyan S, Dutta RK, Nair M, Chand HS, Rahman I, Unwalla HJ. TGF-β1 increases viral burden and promotes HIV-1 latency in primary differentiated human bronchial epithelial cells. Sci Rep. 2019;9(1):12552. doi:10.1038/s41598-019-49056-6
   PubMedGoogle Scholar
• Ayala-Suárez R, Díez-Fuertes F, Calonge E, et al. Insight in miRNome of long-term non-progressors and elite controllers exposes potential RNAi role in restraining HIV-1 infection. J Clin Med. 2020;9(8). doi:10.3390/jcm9082452
   PubMed Web of Science ®Google Scholar
• Amaral AJ, Andrade J, Foxall RB, et al. miRNA profiling of human naive CD4 T cells links miR‐34c‐5p to cell activation and HIV replication. EMBO J. 2017;36(3):346–360. doi:10.15252/embj.201694335
   PubMed Web of Science ®Google Scholar
• Teng Y, Luo M, Yu T, et al. CRISPR/Cas9-mediated deletion of miR-146a enhances antiviral response in HIV-1 infected cells. Genes Immun. 2019;20(4):327–337. doi:10.1038/s41435-018-0036-x
   PubMed Web of Science ®Google Scholar
• Okoye I, Xu L, Oyegbami O, et al. Plasma extracellular vesicles enhance HIV-1 infection of activated CD4(+) T cells and promote the activation of latently infected J-Lat10.6 cells via miR-139-5p transfer. Front Immunol. 2021;12:697604. doi:10.3389/fimmu.2021.697604
   PubMed Web of Science ®Google Scholar
• Jordan A, Bisgrove D, Verdin E. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 2003;22(8):1868–1877. doi:10.1093/emboj/cdg188
   PubMed Web of Science ®Google Scholar
• Roux A, Leroy H, De Muylder B, et al. FOXO1 transcription factor plays a key role in T cell-HIV-1 interaction. PLoS Pathog. 2019;15(5):e1007669. doi:10.1371/journal.ppat.1007669
   PubMed Web of Science ®Google Scholar
• Patel P, Ansari MY, Bapat S, Thakar M, Gangakhedkar R, Jameel S. The microRNA miR-29a is associated with human immunodeficiency virus latency. Retrovirology. 2014;11:108. doi:10.1186/s12977-014-0108-6
   PubMed Web of Science ®Google Scholar
• Ahluwalia JK, Khan SZ, Soni K, et al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology. 2008;5:117. doi:10.1186/1742-4690-5-117
   PubMed Web of Science ®Google Scholar
• Nathans R, Chu C-Y, Serquina AK, Lu -C-C, Cao H, Rana TM. Cellular microRNA and P-bodies modulate host-HIV-1 interactions. Mol Cell. 2009;34(6):696–709. doi:10.1016/j.molcel.2009.06.003
   PubMed Web of Science ®Google Scholar
• Luo Y, Na Z, Slavoff SA. P-bodies: composition, properties, and functions. Biochemistry. 2018;57(17):2424–2431. doi:10.1021/acs.biochem.7b01162
   PubMed Web of Science ®Google Scholar
• Huang J, Wang F, Argyris E, et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med. 2007;13:1241–1247. doi:10.1038/nm1639
   PubMed Web of Science ®Google Scholar
• López-Huertas MR, Morín M, Madrid-Elena N, et al. Selective miRNA modulation fails to activate HIV replication in in vitro latency models. Mol Ther Nucleic Acids. 2019;17:323–336. doi:10.1016/j.omtn.2019.06.006
   PubMedGoogle Scholar
• Woldemeskel BA, Kwaa AK, Blankson JN. Viral reservoirs in elite controllers of HIV-1 infection: implications for HIV cure strategies. EBioMedicine. 2020;62:103118. doi:10.1016/j.ebiom.2020.103118
   PubMed Web of Science ®Google Scholar
• Trypsteen W, White CH, Mukim A, et al. Long non-coding RNAs and latent HIV – a search for novel targets for latency reversal. PLoS One. 2019;14(11):e0224879. doi:10.1371/journal.pone.0224879
   PubMed Web of Science ®Google Scholar
• Matsuda S, Akagawa K, Honda M, Yokota Y, Takebe Y, Takemori T. Suppression of HIV replication in human monocyte-derived macrophages induced by granulocyte/macrophage colony-stimulating factor. AIDS Res Hum Retroviruses. 1995;11(9):1031–1038. doi:10.1089/aid.1995.11.1031
   PubMed Web of Science ®Google Scholar
• Vemula SV, Maxwell JW, Nefedov A, et al. Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivation. Antiviral Res. 2017;139:161–170. doi:10.1016/j.antiviral.2016.11.014
   PubMed Web of Science ®Google Scholar
• Yamada K, Lim J, Dale JM, et al. Empirical analysis of transcriptional activity in the Arabidopsis genome. Science. 2003;302(5646):842–846. doi:10.1126/science.1088305
   PubMed Web of Science ®Google Scholar
• Li H, Chi X, Li R, Ouyang J, Chen Y. A novel lncRNA, AK130181, contributes to HIV-1 latency by regulating viral promoter-driven gene expression in primary CD4(+) T cells. Mol Ther Nucleic Acids. 2020;20:754–763. doi:10.1016/j.omtn.2020.04.011
   PubMedGoogle Scholar
• Liu B, Sun L, Liu Q, et al. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis. Cancer Cell. 2015;27(3):370–381. doi:10.1016/j.ccell.2015.02.004
   PubMed Web of Science ®Google Scholar
• Wang H, Liu Y, Huan C, et al. NF-κB-interacting long noncoding RNA regulates HIV-1 replication and latency by repressing NF-κB signaling. J Virol. 2020;94(17). doi:10.1128/JVI.01057-20
   Web of Science ®Google Scholar
• Guan Y, Kuo WL, Stilwell JL, et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res. 2007;13(19):5745–5755. doi:10.1158/1078-0432.CCR-06-2882
   PubMed Web of Science ®Google Scholar
• Carramusa L, Contino F, Ferro A, et al. The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J Cell Physiol. 2007;213(2):511–518. doi:10.1002/jcp.21133
   PubMed Web of Science ®Google Scholar
• Guo J, Hao C, Wang C, Li L. Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2. Cancer Cell Int. 2018;18:98. doi:10.1186/s12935-018-0582-3
   PubMed Web of Science ®Google Scholar
• Tripathy MK, McManamy MEM, Burch BD, Archin NM, Margolis DM. H3K27 demethylation at the proviral promoter sensitizes latent HIV to the effects of vorinostat in ex-vivo cultures of resting CD4+ T cells. J Virol. 2015;89:8392–8405. doi:10.1128/JVI.00572-15
   PubMed Web of Science ®Google Scholar
• Qu D, Sun -W-W, Li L, et al. Long noncoding RNA MALAT1 releases epigenetic silencing of HIV-1 replication by displacing the polycomb repressive complex 2 from binding to the LTR promoter. Nucleic Acids Res. 2019;47(6):3013–3027. doi:10.1093/nar/gkz117
   PubMed Web of Science ®Google Scholar
• Chao T-C, Zhang Q, Li Z, et al. The long noncoding RNA HEAL regulates HIV-1 replication through epigenetic regulation of the HIV-1 promoter. mBio. 2019;10(5):e02016–02019. doi:10.1128/mBio.02016-19
   PubMed Web of Science ®Google Scholar
• Huan C, Li Z, Ning S, Wang H, Yu X-F, Zhang W. Long noncoding RNA uc002yug.2 activates HIV-1 latency through regulation of mRNA levels of various RUNX1 isoforms and increased Tat expression. J Virol. 2018;92(9). doi:10.1128/JVI.01844-17
   Web of Science ®Google Scholar
• Zhang Q, Chen C-Y, Yedavalli VS, Jeang K-T. NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. mBio. 2013;4(1):e00596–00512. doi:10.1128/mBio.00596-12
   PubMed Web of Science ®Google Scholar
• Bond CS, Fox AH. Paraspeckles: nuclear bodies built on long noncoding RNA. J Cell Biol. 2009;186(5):637–644. doi:10.1083/jcb.200906113
   PubMed Web of Science ®Google Scholar
• Zolotukhin AS, Michalowski D, Bear J, et al. PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression. Mol Cell Biol. 2003;23(18):6618–6630. doi:10.1128/MCB.23.18.6618-6630.2003
   PubMed Web of Science ®Google Scholar
• Schwartz S, Felber BK, Pavlakis GN. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of rev protein. J Virol. 1992;66(1):150–159. doi:10.1128/jvi.66.1.150-159.1992
   PubMed Web of Science ®Google Scholar
• Liu H, Hu P-W, Couturier J, Lewis DE, Rice AP. HIV-1 replication in CD4+ T cells exploits the down-regulation of antiviral NEAT1 long non-coding RNAs following T cell activation. Virology. 2018;522:193–198. doi:10.1016/j.virol.2018.07.020
   PubMed Web of Science ®Google Scholar
• Imam H, Shahr Bano A, Patel P, Holla P, Jameel S. The lncRNA NRON modulates HIV-1 replication in a NFAT-dependent manner and is differentially regulated by early and late viral proteins. Sci Rep. 2015;5(1):8639. doi:10.1038/srep08639
   PubMedGoogle Scholar
• Li J, Chen C, Ma X, et al. Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing Tat protein degradation. Nat Commun. 2016;7(1):11730. doi:10.1038/ncomms11730
   PubMedGoogle Scholar
• Schynkel T, Szaniawski MA, Spivak AM, et al. Interferon-mediated long non-coding RNA response in macrophages in the context of HIV. Int J Mol Sci. 2020;21(20):7741. doi:10.3390/ijms21207741
   PubMed Web of Science ®Google Scholar
• Kambara H, Niazi F, Kostadinova L, et al. Negative regulation of the interferon response by an interferon-induced long non-coding RNA. Nucleic Acids Res. 2014;42(16):10668–10680. doi:10.1093/nar/gku713
   PubMed Web of Science ®Google Scholar
• Chen Q, Cai J, Wang Q, et al. Long noncoding RNA NEAT1, regulated by the EGFR pathway, contributes to glioblastoma progression through the WNT/β-catenin pathway by scaffolding EZH2. Clin Cancer Res. 2018;24(3):684–695. doi:10.1158/1078-0432.CCR-17-0605
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu L, Zhang S, et al. Long noncoding RNA NEAT1 suppresses hepatocyte proliferation in fulminant hepatic failure through increased recruitment of EZH2 to the LATS2 promoter region and promotion of H3K27me3 methylation. Exp Mol Med. 2020;52(3):461–472. doi:10.1038/s12276-020-0387-z
   PubMed Web of Science ®Google Scholar
• Zhou Q, Chen J, Feng J, Wang J. Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR). Tumor Biol. 2016;37(3):3105–3113. doi:10.1007/s13277-015-4149-9
   PubMedGoogle Scholar
• Chen L, Chen L, Zuo L, et al. Short communication: long noncoding RNA GAS5 inhibits HIV-1 replication through interaction with miR-873. AIDS Res Hum Retroviruses. 2018;34(6):544–549. doi:10.1089/aid.2017.0177
   PubMed Web of Science ®Google Scholar
• Chang Z, Cui J, Song Y. Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer. Gene. 2018;654:36–42. doi:10.1016/j.gene.2018.02.036
   PubMed Web of Science ®Google Scholar
• Lan T, Yan X, Li Z, et al. Long non-coding RNA PVT1 serves as a competing endogenous RNA for miR-186-5p to promote the tumorigenesis and metastasis of hepatocellular carcinoma. Tumour Biol. 2017;39(6):1010428317705338. doi:10.1177/1010428317705338
   Google Scholar
• Huang T, Liu HW, Chen JQ, et al. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer. Biomed Pharmacother. 2017;88:302–308. doi:10.1016/j.biopha.2017.01.049
   PubMed Web of Science ®Google Scholar
• Lu X, Yu Y, Yin F, et al. Knockdown of PVT1 inhibits IL-1β-induced injury in chondrocytes by regulating miR-27b-3p/TRAF3 axis. Int Immunopharmacol. 2020;79:106052. doi:10.1016/j.intimp.2019.106052
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang Q, Sun Y, Shao F. Long non-coding RNA PVT1 regulates BAMBI to promote tumor progression in non-small cell lung cancer by sponging miR-17-5p. Onco Targets Ther. 2020;13:131–142. doi:10.2147/OTT.S217335
   PubMed Web of Science ®Google Scholar
• Yuan W, Xiong X, Du J, Fan Q, Wang R, Zhang X. LncRNA PVT1 accelerates LPS-induced septic acute kidney injury through targeting miR-17-5p and regulating NF-κB pathway. Int Urol Nephrol. 2021;53(11):2409–2419. doi:10.1007/s11255-021-02905-8
   PubMed Web of Science ®Google Scholar
• Huang F, Chen W, Peng J, et al. Retracted article: lncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 axis. Mol Cancer. 2018;17(1):98. doi:10.1186/s12943-018-0845-6
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Z, Jiang H, et al. Circular RNA circPVT1 promotes proliferation and invasion through sponging miR-125b and activating E2F2 signaling in non-small cell lung cancer. Cell Physiol Biochem. 2018;51(5):2324–2340. doi:10.1159/000495876
   PubMedGoogle Scholar
• Jadlowsky JK, Wong JY, Graham AC, et al. Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat. Mol Cell Biol. 2014;34(11):1911–1928. doi:10.1128/MCB.01013-13
   PubMed Web of Science ®Google Scholar
• Lin X, Irwin D, Kanazawa S, et al. Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir. J Virol. 2003;77(15):8227–8236. doi:10.1128/JVI.77.15.8227-8236.2003
   PubMed Web of Science ®Google Scholar
• Adams M, Sharmeen L, Kimpton J, et al. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Nat Acad Sci U S A. 1994;91:3862–3866. doi:10.1073/pnas.91.9.3862
   PubMed Web of Science ®Google Scholar
• Barclay RA, Schwab A, DeMarino C, et al. Exosomes from uninfected cells activate transcription of latent HIV-1. J Biol Chem. 2017;292(28):11682–11701. doi:10.1074/jbc.M117.793521
   PubMed Web of Science ®Google Scholar
• Pinto DO, Scott TA, DeMarino C, et al. Effect of transcription inhibition and generation of suppressive viral non-coding RNAs. Retrovirology. 2019;16(1):13. doi:10.1186/s12977-019-0475-0
   PubMedGoogle Scholar
• Schopman NC, Willemsen M, Liu YP, et al. Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res. 2012;40(1):414–427. doi:10.1093/nar/gkr719
   PubMed Web of Science ®Google Scholar
• Klase Z, Kale P, Winograd R, et al. HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol. 2007;8:63. doi:10.1186/1471-2199-8-63
   PubMed Web of Science ®Google Scholar
• Ouellet DL, Plante I, Landry P, et al. Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res. 2008;36(7):2353–2365. doi:10.1093/nar/gkn076
   PubMed Web of Science ®Google Scholar
• Klase Z, Winograd R, Davis J, et al. HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology. 2009;6(1):18. doi:10.1186/1742-4690-6-18
   PubMedGoogle Scholar
• Ouellet DL, Vigneault-Edwards J, Létourneau K, et al. Regulation of host gene expression by HIV-1 TAR microRNAs. Retrovirology. 2013;10(1):86. doi:10.1186/1742-4690-10-86
   PubMedGoogle Scholar
• Harwig A, Jongejan A, van Kampen AH, Berkhout B, Das AT. Tat-dependent production of an HIV-1 TAR-encoded miRNA-like small RNA. Nucleic Acids Res. 2016;44(9):4340–4353. doi:10.1093/nar/gkw167
   PubMed Web of Science ®Google Scholar
• Li L, Feng H, Da Q, et al. Expression of HIV-encoded microRNA-TAR and its inhibitory effect on viral replication in human primary macrophages. Arch Virol. 2016;161(5):1115–1123. doi:10.1007/s00705-016-2755-5
   PubMed Web of Science ®Google Scholar
• Omoto S, Ito M, Tsutsumi Y, et al. HIV-1 nef suppression by virally encoded microRNA. Retrovirology. 2004;1(1):44. doi:10.1186/1742-4690-1-44
   PubMedGoogle Scholar
• Omoto S, Fujii YR. Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J Gen Virol. 2005;86(3):751–755. doi:10.1099/vir.0.80449-0
   PubMedGoogle Scholar
• Yamamoto T, Omoto S, Mizuguchi M, et al. Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication. Microbiol Immunol. 2002;46(11):809–817. doi:10.1111/j.1348-0421.2002.tb02768.x
   PubMed Web of Science ®Google Scholar
• Zhang Y, Fan M, Geng G, et al. A novel HIV-1-encoded microRNA enhances its viral replication by targeting the TATA box region. Retrovirology. 2014;11(1):23. doi:10.1186/1742-4690-11-23
   PubMedGoogle Scholar
• Kaul D, Ahlawat A, Gupta SD. HIV-1 genome-encoded hiv1-mir-H1 impairs cellular responses to infection. Mol Cell Biochem. 2009;323(1–2):143–148. doi:10.1007/s11010-008-9973-4
   PubMed Web of Science ®Google Scholar
• Kaul D, Khanna A. Evidence and nature of a novel miRNA encoded by HIV-1. Proc Indian Nat Sci Acad. 2006;72(2):91–95.
   Google Scholar
• Hariharan M, Scaria V, Pillai B, Brahmachari SK. Targets for human encoded microRNAs in HIV genes. Biochem Biophys Res Commun. 2005;337(4):1214–1218. doi:10.1016/j.bbrc.2005.09.183
   PubMed Web of Science ®Google Scholar
• Leister P, Burgdorf S, Scheidtmann KH. Apoptosis antagonizing transcription factor AATF is a novel coactivator of nuclear hormone receptors. Signal Transduct. 2003;3(1–2):17–25. doi:10.1002/sita.200300020
   Google Scholar
• Felzien LK, Woffendin C, Hottiger MO, Subbramanian RA, Cohen EA, Nabel GJ. HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. Proc Natl Acad Sci U S A. 1998;95(9):5281–5286. doi:10.1073/pnas.95.9.5281
   PubMed Web of Science ®Google Scholar
• Kaul D, Hussain A. Cellular AATF gene encodes a novel miRNA that can contribute to HIV-1 latency. Indian J Biochem Biophys. 2009;46(3):237–240.
   PubMed Web of Science ®Google Scholar
• Michael NL, Vahey MT, d’Arcy L, et al. Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat. J Virol. 1994;68(2):979–987. doi:10.1128/jvi.68.2.979-987.1994
   PubMed Web of Science ®Google Scholar
• Vanhée-Brossollet C, Thoreau H, Serpente N, D’Auriol L, Lévy JP, Vaquero C. A natural antisense RNA derived from the HIV-1 env gene encodes a protein which is recognized by circulating antibodies of HIV+ individuals. Virology. 1995;206(1):196–202. doi:10.1016/S0042-6822(95)80034-4
   PubMed Web of Science ®Google Scholar
• Tagieva NE, Vaquero C. Expression of naturally occurring antisense RNA inhibits human immunodeficiency virus type 1 heterologous strain replication. J Gen Virol. 1997;78(Pt 10):2503–2511. doi:10.1099/0022-1317-78-10-2503
   PubMedGoogle Scholar
• Ludwig L, Ambrus J, Krawczyk K, et al. Human immunodeficiency virus-type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products. Retrovirology. 2006;3(1):80. doi:10.1186/1742-4690-3-80
   PubMedGoogle Scholar
• Landry S, Halin M, Lefort S, et al. Detection, characterization and regulation of antisense transcripts in HIV-1. Retrovirology. 2007;4(1):71. doi:10.1186/1742-4690-4-71
   PubMedGoogle Scholar
• Kobayashi-Ishihara M, Yamagishi M, Hara T, et al. HIV-1-encoded antisense RNA suppresses viral replication for a prolonged period. Retrovirology. 2012;9(1):38. doi:10.1186/1742-4690-9-38
   PubMedGoogle Scholar
• Saayman S, Ackley A, Turner AW, et al. An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription. Mol Ther. 2014;22(6):1164–1175. doi:10.1038/mt.2014.29
   PubMed Web of Science ®Google Scholar
• Wiegand A, Spindler J, Hong FF, et al. Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART. Proc Natl Acad Sci U S A. 2017;114(18):E3659–E3668. doi:10.1073/pnas.1617961114
   PubMed Web of Science ®Google Scholar
• Yukl SA, Kaiser P, Kim P, et al. HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing. Sci Transl Med. 2018;10(430). doi:10.1126/scitranslmed.aap9927
   PubMed Web of Science ®Google Scholar
• Ishizaka A, Sato H, Nakamura H, et al. Short intracellular HIV-1 transcripts as biomarkers of residual immune activation in patients on antiretroviral therapy. J Virol. 2016;90(12):5665–5676. doi:10.1128/JVI.03158-15
   PubMed Web of Science ®Google Scholar
• Kaiser P, Joshi SK, Kim P, et al. Assays for precise quantification of total (including short) and elongated HIV-1 transcripts. J Virol Methods. 2017;242:1–8. doi:10.1016/j.jviromet.2016.12.017
   PubMed Web of Science ®Google Scholar
• Lassen KG, Bailey JR, Siliciano RF. Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4ȡ + T cells in vivo. J Virol. 2004;78(17):9105–9114. doi:10.1128/JVI.78.17.9105-9114.2004
   PubMed Web of Science ®Google Scholar
• Boliar S, Russell DG. Lnc(ing)RNAs to the “shock and kill” strategy for HIV-1 cure. Mol Ther Nucleic Acids. 2021;23:1272–1280. doi:10.1016/j.omtn.2021.02.004
   PubMedGoogle Scholar